ERD

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

01-09-2024

-

31-08-2031

Show more information

Organisation SKANE LANS LANDSTING

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

01-05-2023

-

30-04-2026

Show more information

Organisation SKANE LANS LANDSTING

INNODIA | Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

01-11-2015

-

31-10-2023

Show more information

Organisation SKANE LANS LANDSTING

ARCADIA | TrAnsformative climate ResilienCe by nAture-baseD solutions in the contInentAl bio-geographical region

01-01-2024

-

30-06-2028

Show more information

Organisation SKANE LANS LANDSTING

Procure4Health | Healthcare Innovation Procurement Network

01-06-2022

-

31-05-2025

Show more information

Organisation SKANE LANS LANDSTING

PAPA-ARTIS | Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial

01-01-2017

-

30-09-2024

Show more information

Organisation SKANE LANS LANDSTING

PRIME-ROSE | PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

01-07-2023

-

30-06-2028

Show more information

Organisation SKANE LANS LANDSTING

BIOCYCLE | BIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease

01-04-2015

-

31-12-2022

Show more information

Organisation SKANE LANS LANDSTING

HEDIMED | Human Exposomic Determinants of Immune Mediated Diseases

01-01-2020

-

31-12-2024

Show more information

Organisation SKANE LANS LANDSTING

Invest4Health | Mobilising novel finance models for health promotion and disease prevention

01-01-2023

-

30-06-2026

Show more information

Organisation SKANE LANS LANDSTING

iLIVE | Living well, dying well. A research programme to support living until the end

01-01-2019

-

31-12-2023

Show more information

Organisation SKANE LANS LANDSTING

SYNDEGEN | Synaptic dysfunction in Neurodegenerative Diseases

01-01-2017

-

30-06-2021

Show more information

Organisation SKANE LANS LANDSTING

TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery

01-01-2017

-

31-12-2020

Show more information

Organisation SKANE LANS LANDSTING

PREPARE | An EU-wide springboard for regional implementation of innovation procurement

01-12-2023

-

30-11-2024

Show more information

Organisation SKANE LANS LANDSTING

Carematrix PCP | Pre-commercial procurement for integrated CARE solutions addressing the Multimorbidity mATRIX in ageing populations

01-03-2021

-

31-12-2025

Show more information

Organisation SKANE LANS LANDSTING

Projects overview

Selected filters:

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

INNODIA | Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

ARCADIA | TrAnsformative climate ResilienCe by nAture-baseD solutions in the contInentAl bio-geographical region

Procure4Health | Healthcare Innovation Procurement Network

PAPA-ARTIS | Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial

PRIME-ROSE | PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

BIOCYCLE | BIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease

HEDIMED | Human Exposomic Determinants of Immune Mediated Diseases

Invest4Health | Mobilising novel finance models for health promotion and disease prevention

iLIVE | Living well, dying well. A research programme to support living until the end

SYNDEGEN | Synaptic dysfunction in Neurodegenerative Diseases

TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery

PREPARE | An EU-wide springboard for regional implementation of innovation procurement

Carematrix PCP | Pre-commercial procurement for integrated CARE solutions addressing the Multimorbidity mATRIX in ageing populations